Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing management, economic, and financial consulting services, today announced that Dr. David Campbell has joined the firm as a vice president in the Life Sciences Practice based in London. Dr. Campbell is an experienced consultant specializing in strategy issues confronting life sciences industries in Europe and emerging markets. “We are pleased to welcome David Campbell to CRA,” said CRA's President and Chief Executive Officer Paul Maleh. “His experience as a management consultant and specialist in Europe and emerging markets, combined with his experience working in industry at leading global pharmaceutical companies, is a strong addition to our global offering in life sciences.” Dr. Campbell joins CRA from IMS Consulting Group where he was a senior principal. Prior to that role, he was a management consultant and managing partner with Catenion Strategies GmbH specializing in the pharmaceutical, biotechnology, and diagnostics industries. He began his career in research roles at various hospitals throughout the UK and then worked in industry at SmithKline Beechams Pharmaceuticals, UK and GlaxoSmithKline, UK. Dr. Campbell has led numerous projects in the areas of market entry strategy, emerging markets, portfolio analysis, brand and commercial strategy, and pricing and market access through an extensive network of C-level clients across a broad range of global organizations. He has written and contributed to a number of publications on strategic issues in the life sciences industry. About Charles River Associates (CRA) Charles River Associates® is a global consulting firm specializing in litigation, regulatory, and financial consulting, and management consulting. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout North America, Europe, the Middle East, and Asia. Detailed information about Charles River Associates, a registered trade name of CRA International, Inc., is available at http://www.crai.com.
Shares of CRA International (Nasdaq:CRAI) have taken a tremendous swing upward. The stock is trading at $24.92 as of 11:21 a.m. ET, 23.4% above Wednesday's closing price of $20.19. Volume is at 20,984, 0.5 times the daily average of 40,100.